Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Giardina

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Biochemical Pharmacology|April 30, 2013
Intestinal organoids as tissue surrogates for toxicological and pharmacological studiesAnton Kuratnik, Charles Giardina
Cell Stress & Chaperones|October 17, 2002
Growing old with nuclear factor-kappaBCharles Giardina, Andrea K Hubbard
Biochemical and Biophysical Research Communications|April 6, 2004
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibitionXin Tong, Lei Yin, Charles Giardina
The Journal of Biological Chemistry|December 17, 2013
Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosisAvijeet Chopra, Amy Anderson, Charles Giardina
Experimental Cell Research|June 27, 2008
Hsp70B' and Hsp72 form a complex in stressed human colon cells and each contributes to cytoprotectionEmily Noonan, Charles Giardina, Lawrence Hightower
Biochemical Pharmacology|February 25, 2021
Ferroptosis and its potential as a therapeutic targetHanshu Yuan, Justin Pratte, Charles Giardina
Journal of Cellular Physiology|April 22, 2003
Induced stabilization of IkappaBalpha can facilitate its re-synthesis and prevent sequential degradationRobert F Place, Derek Haspeslagh, Charles Giardina
Carcinogenesis|November 28, 2008
Mouse models for the study of colon carcinogenesisDaniel W Rosenberg, Charles Giardina, Takuji Tanaka
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2013
Quantitation of nucleosome acetylation and other histone posttranslational modifications using microscale NU-ELISABo Dai, Charles Giardina, Theodore P Rasmussen
Biochemical Pharmacology|November 13, 2017
A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeuticallyLauren E Harrison, Marina Bleiler, Charles Giardina
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|April 30, 2013
Intestinal organoids as tissue surrogates for toxicological and pharmacological studiesAnton Kuratnik, Charles Giardina
Cell Stress & Chaperones|October 17, 2002
Growing old with nuclear factor-kappaBCharles Giardina, Andrea K Hubbard
Biochemical and Biophysical Research Communications|April 6, 2004
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibitionXin Tong, Lei Yin, Charles Giardina
The Journal of Biological Chemistry|December 17, 2013
Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosisAvijeet Chopra, Amy Anderson, Charles Giardina
Experimental Cell Research|June 27, 2008
Hsp70B' and Hsp72 form a complex in stressed human colon cells and each contributes to cytoprotectionEmily Noonan, Charles Giardina, Lawrence Hightower
Biochemical Pharmacology|February 25, 2021
Ferroptosis and its potential as a therapeutic targetHanshu Yuan, Justin Pratte, Charles Giardina
Journal of Cellular Physiology|April 22, 2003
Induced stabilization of IkappaBalpha can facilitate its re-synthesis and prevent sequential degradationRobert F Place, Derek Haspeslagh, Charles Giardina
Carcinogenesis|November 28, 2008
Mouse models for the study of colon carcinogenesisDaniel W Rosenberg, Charles Giardina, Takuji Tanaka
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2013
Quantitation of nucleosome acetylation and other histone posttranslational modifications using microscale NU-ELISABo Dai, Charles Giardina, Theodore P Rasmussen
Biochemical Pharmacology|November 13, 2017
A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeuticallyLauren E Harrison, Marina Bleiler, Charles Giardina
Pageof 7